Clinical Trials Logo
  1. Home
  2. Severe Aortic Valve Stenosis
  3. NCT06168123

Future Optimal Research and Care Evaluation - Aortic Stenosis — FORCE-AoS  

Severe Aortic Valve Stenosis Clinical Trial

Official title:
Future Optimal Research and Care Evaluation - Aortic Stenosis

Clinical Trial Summary

In the past decade the treatment of aortic valve stenosis has rapidly changed. At first, transcatheter aortic valve implantation (TAVI) was a last resort option for inoperable patients. Nowadays, it more and more becomes an alternative to surgical aortic valve replacement (SAVR) - also in younger and lower risk patients. This poses important questions to clinical practise regarding the optimal life-time management of each individual patient. Which involves (durability of) treatment modality (surgical vs. transcatheter vs. conservative treatment) as well as the duration and type of the required antithrombotic treatment. Objective: to evaluate the effect of treatment modality (surgical vs. transcatheter vs. conservative treatment) and its complications on quality of life and survival in AoS patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06168123
Study type Observational [Patient Registry]
Source St. Antonius Hospital
Contact Christiaan Overduin
Phone +31 (0)88 320 0931
Email c.overduin@antoniusziekenhuis.nl
Status Recruiting
Phase
Start date November 27, 2023
Completion date August 1, 2027
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05552352 - VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease N/A
Active, not recruiting NCT05182307 - DurAVR™ THV System: First-In-Human Study N/A
Recruiting NCT06156592 - Post Spinal Hemodynamic Changes in Aortic Stenosis and Mitral Regurgitation by VIS Index and Echocardiography
Completed NCT04259723 - Virtual Reality Assisted Conscious Sedation During TAVI N/A
Recruiting NCT05873816 - The PROTEMBO Trial N/A
Recruiting NCT04128384 - Infranodal Conduction Time During TAVR as Predictor of HAVB N/A
Recruiting NCT05024942 - LUS in Aortic Stenosis Patients Undergoing TAVR
Recruiting NCT05283356 - Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation Phase 4
Not yet recruiting NCT05847751 - The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
Completed NCT02224066 - Platelet Reactivity After TAVI: A Multicenter Pilot Study Phase 4
Recruiting NCT06168370 - Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation N/A
Recruiting NCT05097183 - Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation
Active, not recruiting NCT05712161 - Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study N/A
Not yet recruiting NCT04988243 - Multi Center Registry of Transcatheter Aortic Valve Replacement in Northeast China N/A